摘要
p53 基因作为广泛存在的肿瘤抑制基因,在肿瘤发生发展中起着重要作用。最近发现两类与 P53 蛋白具有较大同源性的家族成员:P63 和P73。它们都能激活 P53 相关靶基因,抑制增殖,诱导凋亡,但它们在肿瘤发生及细胞生长发育的调控中各自起着既相关又特别的作用。
出处
《中华肝胆外科杂志》
CAS
CSCD
2005年第2期139-141,共3页
Chinese Journal of Hepatobiliary Surgery
参考文献19
-
1De Laurenzi V,Rossi A,Terrinoni A, et al.P63 and P73 transactivate differentiation gene promoters in human keratinocytes. Biochem Biophys Res Commun, 2000,273: 342-346.
-
2Lu P, Barad M, Vize PP,et al. Xenopus p63 expression in early ectoderm and neurectoderm. Mech Dev, 2001,102: 275-278.
-
3Bokhoven H,Hamel BC, Brimshed M, et al. P63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am J Hum Genet, 2001, 69: 481-492.
-
4Noszczyk BH, Majewski ST. P63 expression during normal cutaneous wound healing in humans. Plast Reconstr Surg, 2001, 108: 1242-1250.
-
5Sasaki Y,Morimoto I, Ishida S ,et al. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer. Gene Ther, 2001, 8: 1401-1408.
-
6Senoo M,Matsumura Y, Habu S, et al. Identification of a novel retrovirus long terminal repeat (LTR) that is targeted by p51A (TAp63gamma) and selective dominant-negative activity of p73L (DeltaNp63al-pha) toward p53-responsive promoter activities. Biochem Biophys Res Commun, 2001, 286: 628-634.
-
7Dohn M, Zhang S, Chen X, et al. P63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene, 2001, 20: 3193-3205.
-
8Liefer KM,Koster MI. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res, 2000, 60: 4016-4020.
-
9Katoh I, Aisaki KI, Rurata SI, et al. P51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation. Oncogene, 2000, 19: 3126-3130.
-
10Kadakia M, Slader C, Berberich SJ, et al. Regulation of p63 function by Mdm2 and MdmX. DNA Cell Biol, 2001, 20: 321-330.
同被引文献6
-
1Mills AA, Zheng B, Wang XJ. p63 is a p53 homologue required for limb and epidermal morphogenesis [ J ]. Nature, 1999,398 (6729) : 708 - 713.
-
2Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities[J]. Mol Cell, 1998, 2(3) :305 - 316.
-
3Ikawa S, Nakagawara A, Lkawa Y. p53 family genes: structural comparison, expression and mutation[J]. Cell Death Differ, 1999,6 (12) : 1154 - 1161.
-
4Kaufmann O, Fietze E, Mengs J, et al, Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas[ J]. Am J Clin Pathol, 2001,116(6) : 823 - 830.
-
5Pellegrini G, Dellambra E, Gollsano O, et al. p63 identifies keratinocyte stem cells[J]. Proc Natl Acad Sci USA, 2001,98(6): 3156 - 3161.
-
6Camilo R, Capelozzi VL, Siqueira SA, et al. Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas[J]. Human Pathology, 2006, 37(5):542-546.
二级引证文献3
-
1宦大为,王翠芳,滕猛.肺大细胞癌伴支气管鳞状细胞乳头状癌且均有神经内分泌分化临床病理观察[J].山东医药,2010,50(16):83-85. 被引量:1
-
2许立莉,李淼,杜明伟,陈江帆,李建华.痰液肺癌细胞Ras基因和P63基因的表达与分子生物学意义[J].中国组织化学与细胞化学杂志,2011,20(6):616-622. 被引量:3
-
3田伟,田延龙,殷喜梅,何小刚.支气管冲洗液细胞块免疫组化染色在肺癌病理诊断中的价值[J].现代肿瘤医学,2014,22(10):2354-2356. 被引量:6
-
1郭莉,王晓红,白淑平.P73基因的研究进展[J].中国伤残医学,2006,14(2):91-92.
-
2纪元,吴乔.p53家族新成员p63和p73[J].癌症,2002,21(10):1164-1167. 被引量:3
-
3贾海英,王继群.p63与头颈部鳞癌[J].国外医学(耳鼻咽喉科学分册),2005,29(1):3-5. 被引量:4
-
4贾海英,王继群.p53家族新成员p63,p73与头颈部肿瘤[J].中国耳鼻咽喉颅底外科杂志,2005,11(4):285-288. 被引量:4
-
5陈明,孙红宇,高天明.p73基因的研究进展[J].国外医学(生理病理科学与临床分册),2000,20(4):261-262. 被引量:1
-
6贾丛林,张晓杰,迟风令,王运杰.神经胶质瘤中P63和P73基因的表达变化[J].神经疾病与精神卫生,2003,3(1):32-35. 被引量:1
-
7贾丛林,张晓杰,迟风令,王运杰.神经胶质瘤中p63和p73基因的表达变化[J].世界肿瘤杂志,2002,1(3):189-192.
-
8孙澜,陆建云,华纲,陆正中,赵斌斌,冯一中.CD105和p63在尖锐湿疣皮损中的表达及临床意义[J].中华皮肤科杂志,2006,39(11):663-663. 被引量:2
-
9郑建明,朱明华,钱海龙,王洋,于观贞,祝峙,倪灿荣.p73和p63蛋白在胰腺癌组织中过表达的意义[J].中华肿瘤防治杂志,2006,13(4):279-282. 被引量:3
-
10谈济洲,许晶晶,刘虹伶,谢思明,沈丽佳.口腔鳞癌及癌前病变中p63蛋白表达的研究[J].中国医学创新,2012,9(21):3-5.